Improving the tools of clinical pharmacology: Goals for 2017 and beyond

I. Zineh; D. Abernethy; C. E.C.A. Hop; A. Bello; M. B. McClellan; G. W. Daniel; M. H. Romine

doi:10.1002/cpt.530

Improving the tools of clinical pharmacology: Goals for 2017 and beyond

I. Zineh, D. Abernethy, C. E.C.A. Hop, A. Bello, M. B. McClellan, G. W. Daniel, M. H. Romine

School of Medicine

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trends in late-stage attrition and increase the efficiency of drug development and evaluation. These recommendations are based, in part, on previous stakeholder engagement and input, as well as a previously published white paper.

Original language	English (US)
Pages (from-to)	22-24
Number of pages	3
Journal	Clinical pharmacology and therapeutics
Volume	101
Issue number	1
DOIs	https://doi.org/10.1002/cpt.530
State	Published - Jan 1 2017

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

Access to Document

10.1002/cpt.530

Cite this

@article{96033ea86b58406bb9f0f35ef0af9638,

title = "Improving the tools of clinical pharmacology: Goals for 2017 and beyond",

abstract = "Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trends in late-stage attrition and increase the efficiency of drug development and evaluation. These recommendations are based, in part, on previous stakeholder engagement and input, as well as a previously published white paper.",

author = "I. Zineh and D. Abernethy and Hop, {C. E.C.A.} and A. Bello and McClellan, {M. B.} and Daniel, {G. W.} and Romine, {M. H.}",

note = "Publisher Copyright: {\textcopyright} 2016 ASCPT",

year = "2017",

month = jan,

day = "1",

doi = "10.1002/cpt.530",

language = "English (US)",

volume = "101",

pages = "22--24",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Improving the tools of clinical pharmacology

T2 - Goals for 2017 and beyond

AU - Zineh, I.

AU - Abernethy, D.

AU - Hop, C. E.C.A.

AU - Bello, A.

AU - McClellan, M. B.

AU - Daniel, G. W.

AU - Romine, M. H.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trends in late-stage attrition and increase the efficiency of drug development and evaluation. These recommendations are based, in part, on previous stakeholder engagement and input, as well as a previously published white paper.

AB - Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology methods and frameworks can help ameliorate these trends in late-stage attrition and increase the efficiency of drug development and evaluation. These recommendations are based, in part, on previous stakeholder engagement and input, as well as a previously published white paper.

UR - http://www.scopus.com/inward/record.url?scp=85006056656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006056656&partnerID=8YFLogxK

U2 - 10.1002/cpt.530

DO - 10.1002/cpt.530

M3 - Article

C2 - 27727433

AN - SCOPUS:85006056656

SN - 0009-9236

VL - 101

SP - 22

EP - 24

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 1

ER -

Improving the tools of clinical pharmacology: Goals for 2017 and beyond

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this